On a shopping spree, Allergan bags CoolSculpting tech in $2.5B buyout; Akebia strikes research deal with J&J
• Botox-maker Allergan has bagged a new company for its medical aesthetics portfolio, paying $2.47 billion for Pleasanton, CA-based Zeltiq Aesthetics $ZLTQ. Zeltiq made its rep with what it calls “CoolSculpting” tech, eliminating pockets of fat by cooling down fat cells. Allergan has been on a shopping spree for more than a year now as it builds up a pipeline of new drugs alongside its aesthetics business.
Unlock this article instantly by becoming a free subscriber.
You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.